Detalhe da pesquisa
1.
Helping themselves: optimal virus-specific CD4 T cell responses require help via CD4 T cell licensing of dendritic cells.
J Immunol
; 193(11): 5420-33, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25339661
2.
Unlike CD4+ T-cell help, CD28 costimulation is necessary for effective primary CD8+ T-cell influenza-specific immunity.
Eur J Immunol
; 42(7): 1744-54, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22585421
3.
IDentif.AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 Intervention.
ACS Nano
; 16(9): 15141-15154, 2022 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977379
4.
First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults.
Infect Dis Ther
; 11(5): 1999-2015, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36058990
5.
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody.
PLoS One
; 16(6): e0253487, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161386
6.
The linear range for accurately quantifying antigen-specific T-cell frequencies by tetramer staining during natural immune responses.
Eur J Immunol
; 41(5): 1499-500, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21469136
7.
Influenza-induced, helper-independent CD8+ T cell responses use CD40 costimulation at the late phase of the primary response.
J Leukoc Biol
; 93(1): 145-54, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23108101